Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
暂无分享,去创建一个
W. Couser | W. Bennett | S. Shankland | E. Burdmann | C. Hugo | S J Shankland | W M Bennett | R. Pichler | T. Andoh | W G Couser | R H Pichler | N Franceschini | B A Young | C Hugo | T F Andoh | E A Burdmann | C E Alpers | N. Franceschini | B. Young | C. Alpers | Richard J. Johnson | C. E. Alpers | Christian Hugo | Nora Franceschini | Bessie A. Young | Emmanuel A. Burdmann | William M. Bennelt
[1] F. Blattner,et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection , 1989, The Journal of experimental medicine.
[2] W. Couser,et al. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. , 1995, Kidney international.
[3] T. Inagami,et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. , 1990, Kidney international.
[4] J. Seyer,et al. Isolation, characterization and immunolocalization of a 53-kDal dentin sialoprotein (DSP). , 1992, Matrix.
[5] N. Schor,et al. Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. , 1987, Kidney international.
[6] P. Wilson,et al. Age and development‐related changes in osteopontin and nitric oxide synthase mRNA levels in human kidney proximal tubule epithelial cells: Contrasting responses to hypoxia and reoxygenation , 1994, Journal of cellular physiology.
[7] W. Bennett,et al. Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. , 1993, Journal of the American Society of Nephrology : JASN.
[8] S. Adler,et al. Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex. , 1991, Kidney international.
[9] C. Alpers,et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.
[10] M. Brezis,et al. Hypoxia of the renal medulla--its implications for disease. , 1995, The New England journal of medicine.
[11] S. Yamamoto,et al. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. , 1990, The Journal of biological chemistry.
[12] B. Julian,et al. Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients. , 1993, Journal of the American Society of Nephrology : JASN.
[13] M. Post,et al. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. , 1991, Kidney international.
[14] W. Bennett,et al. MODIFICATION OF EXPERIMENTAL NEPHROTOXICITY WITH FISH OIL AS THE VEHICLE FOR CYCLOSPORINE , 1987, Transplantation.
[15] S. Wahl,et al. Inflammatory and immunomodulatory roles of TGF-β , 1989 .
[16] C. Alpers,et al. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. , 1995, Kidney international.
[17] T. Ferris,et al. Effect of cyclosporine administration on renal hemodynamics in conscious rats. , 1985, Kidney international.
[18] S. Adler,et al. Cyclosporine induces elevated procollagen α1 (I) mRNA levels in the rat renal cortex , 1991 .
[19] C. Alpers,et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. , 1992, Kidney international.
[20] R. Costa,et al. Acute tubular necrosis in kidney transplant patients treated with enalapril. , 1994, Renal failure.
[21] A. Eddy. Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. , 1994, The American journal of physiology.
[22] D. Dunn,et al. CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.
[23] C. Alpers,et al. Renal injury from angiotensin II-mediated hypertension. , 1992, Hypertension.
[24] J. Conger,et al. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. , 1993, The Journal of clinical investigation.
[25] K. Thai,et al. Expression of transforming growth factor-β1 during diabetic renal hypertrophy , 1994 .
[26] M. Mihatsch,et al. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. , 1988, Clinical nephrology.
[27] L. Truong,et al. Experimental chronic renal ischemia: morphologic and immunologic studies. , 1992, Kidney international.
[28] R. Venuto,et al. Enalapril-associated acute renal failure in renal transplants: possible role of cyclosporine. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] H. Valdimarsson,et al. Renal function and biopsy findings after 5 years' treatment with low‐dose cyclosporin for psoriasis , 1993, The British journal of dermatology.
[30] E. Neilson,et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Alpers,et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.
[32] T. Yamamoto,et al. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. , 1994, Kidney international.
[33] C. Alpers,et al. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). , 1994, The American journal of pathology.
[34] G. Wolf,et al. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. , 1993, The Journal of clinical investigation.
[35] T. Inagami,et al. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. , 1992, Kidney international.
[36] H. Cantor,et al. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo , 1990, The Journal of experimental medicine.
[37] C. Alpers,et al. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. , 1990, The American journal of pathology.
[38] C. Alpers,et al. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. , 1991, Kidney international.
[39] A. Evan,et al. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. , 1995, The American journal of physiology.
[40] R. Nussenblatt,et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. , 1986, The New England journal of medicine.
[41] T. Meyer,et al. The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. , 1993, Journal of the American Society of Nephrology : JASN.